{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:35:23Z","timestamp":1794522923455,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970413"],"award-info":[{"award-number":["31970413"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ufm1-specific ligase 1 (Ufl1) and Ufm1-binding protein 1 (Ufbp1), as putative targets of ubiquitin-fold modifier 1 (Ufm1), have been implicated in several pathogenesis-related signaling pathways. However, little is known about their functional roles in liver disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Hepatocyte-specific <jats:italic>Ufl1<\/jats:italic><jats:sup>\u0394\/\u0394hep<\/jats:sup> and <jats:italic>Ufbp1<\/jats:italic><jats:sup>\u0394\/\u0394hep<\/jats:sup> mice were used to study their role in liver injury. Fatty liver disease and liver cancer were induced by high-fat diet (HFD) and diethylnitrosamine (DEN) administration, respectively. iTRAQ analysis was employed to screen for downstream targets affected by Ufbp1 deletion. Co-immunoprecipitation was used to determine the interactions between the Ufl1\/Ufbp1 complex and the mTOR\/G\u03b2L complex.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p><jats:italic>Ufl1<\/jats:italic><jats:sup>\u0394\/\u0394hep<\/jats:sup> or <jats:italic>Ufbp1<\/jats:italic><jats:sup>\u0394\/\u0394hep<\/jats:sup> mice exhibited hepatocyte apoptosis and mild steatosis at 2\u00a0months of age and hepatocellular ballooning, extensive fibrosis, and steatohepatitis at 6\u20138\u00a0months of age. More than 50% of <jats:italic>Ufl1<\/jats:italic><jats:sup>\u0394\/\u0394hep<\/jats:sup> and <jats:italic>Ufbp1<\/jats:italic><jats:sup>\u0394\/\u0394hep<\/jats:sup> mice developed spontaneous hepatocellular carcinoma (HCC) by 14\u00a0months of age. Moreover, <jats:italic>Ufl1<\/jats:italic><jats:sup>\u0394\/\u0394hep<\/jats:sup> and <jats:italic>Ufbp1<\/jats:italic><jats:sup>\u0394\/\u0394hep<\/jats:sup> mice were more susceptible to HFD-induced fatty liver and DEN-induced HCC. Mechanistically, the Ufl1\/Ufbp1 complex directly interacts with the mTOR\/G\u03b2L complex and attenuates mTORC1 activity. Ablation of <jats:italic>Ufl1<\/jats:italic> or <jats:italic>Ufbp1<\/jats:italic> in hepatocytes dissociates them from the mTOR\/G\u03b2L complex and activates oncogenic mTOR signaling to drive HCC development.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings reveal the potential role of Ufl1 and Ufbp1 as gatekeepers to prevent liver fibrosis and subsequent steatohepatitis and HCC development by inhibiting the mTOR pathway.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13046-023-02681-6","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T02:01:33Z","timestamp":1683079293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Loss of Ufl1\/Ufbp1 in hepatocytes promotes liver pathological damage and carcinogenesis through activating mTOR signaling"],"prefix":"10.1186","volume":"42","author":[{"given":"Fanghui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianci","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reid","family":"Loveless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1856-7289","authenticated-orcid":false,"given":"Yong","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"key":"2681_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/hep.29115","volume":"66","author":"DJT Bruden","year":"2017","unstructured":"Bruden DJT, McMahon BJ, Townshend-Bulson L, Gounder P, Gove J, Plotnik J, Homan C, Hewitt A, Barbour Y, Spradling PR, Simons BC, McArdle S, Bruce M. Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort. Hepatology. 2017;66:37\u201345.","journal-title":"Hepatology"},{"key":"2681_CR2","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.1158\/0008-5472.CAN-17-2039","volume":"77","author":"Y Teng","year":"2017","unstructured":"Teng Y, Zhao H, Gao L, Zhang W, Shull AY, Shay C. FGF19 Protects Hepatocellular Carcinoma Cells against Endoplasmic Reticulum Stress via Activation of FGFR4-GSK3beta-Nrf2 Signaling. Cancer Res. 2017;77:6215\u201325.","journal-title":"Cancer Res"},{"key":"2681_CR3","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00535-019-01576-8","volume":"54","author":"S Shimada","year":"2019","unstructured":"Shimada S, Tanaka S. A new era for understanding genetic evolution of multistep carcinogenesis. J Gastroenterol. 2019;54:667\u20138.","journal-title":"J Gastroenterol"},{"key":"2681_CR4","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.jhep.2020.01.019","volume":"72","author":"M Muller","year":"2020","unstructured":"Muller M, Bird TG, Nault JC. The landscape of gene mutations in cirrhosis and hepatocellular carcinoma. J Hepatol. 2020;72:990\u20131002.","journal-title":"J Hepatol"},{"key":"2681_CR5","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1136\/gutjnl-2013-306627","volume":"63","author":"J Bruix","year":"2014","unstructured":"Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 2014;63:844\u201355.","journal-title":"Gut"},{"key":"2681_CR6","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/cphy.c120035","volume":"3","author":"JE Puche","year":"2013","unstructured":"Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Compr Physiol. 2013;3:1473\u201392.","journal-title":"Compr Physiol"},{"key":"2681_CR7","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrendo.2016.124","volume":"12","author":"A Baiceanu","year":"2016","unstructured":"Baiceanu A, Mesdom P, Lagouge M, Foufelle F. Endoplasmic reticulum proteostasis in hepatic steatosis. Nat Rev Endocrinol. 2016;12:710\u201322.","journal-title":"Nat Rev Endocrinol"},{"key":"2681_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1055\/s-0039-1681032","volume":"39","author":"JL Maiers","year":"2019","unstructured":"Maiers JL, Malhi H. Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis. Semin Liver Dis. 2019;39:235\u201348.","journal-title":"Semin Liver Dis"},{"key":"2681_CR9","doi-asserted-by":"publisher","first-page":"e18517","DOI":"10.1371\/journal.pone.0018517","volume":"6","author":"K Lemaire","year":"2011","unstructured":"Lemaire K, Moura RF, Granvik M, Igoillo-Esteve M, Hohmeier HE, Hendrickx N, Newgard CB, Waelkens E, Cnop M, Schuit F. Ubiquitin fold modifier 1 (UFM1) and its target UFBP1 protect pancreatic beta cells from ER stress-induced apoptosis. PLoS ONE. 2011;6:e18517.","journal-title":"PLoS ONE"},{"key":"2681_CR10","doi-asserted-by":"publisher","first-page":"e48587","DOI":"10.1371\/journal.pone.0048587","volume":"7","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Zhang M, Wu J, Lei G, Li H. Transcriptional regulation of the Ufm1 conjugation system in response to disturbance of the endoplasmic reticulum homeostasis and inhibition of vesicle trafficking. PLoS ONE. 2012;7:e48587.","journal-title":"PLoS ONE"},{"key":"2681_CR11","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.tcb.2019.09.005","volume":"29","author":"Y Gerakis","year":"2019","unstructured":"Gerakis Y, Quintero M, Li H, Hetz C. The UFMylation System in Proteostasis and Beyond. Trends Cell Biol. 2019;29:974\u201386.","journal-title":"Trends Cell Biol"},{"key":"2681_CR12","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1074\/jbc.M109.036814","volume":"285","author":"K Tatsumi","year":"2010","unstructured":"Tatsumi K, Sou Y-s, Tada N, Nakamura E, Iemura S-i, Natsume T, Kang SH, Chung CH, Kasahara M, Kominami E. A novel type of E3 ligase for the Ufm1 conjugation system. J Biol Chem. 2010;285:5417\u201327.","journal-title":"J Biol Chem"},{"key":"2681_CR13","doi-asserted-by":"publisher","first-page":"15126","DOI":"10.1074\/jbc.M110.110619","volume":"285","author":"J Wu","year":"2010","unstructured":"Wu J, Lei G, Mei M, Tang Y, Li H. A novel C53\/LZAP-interacting protein regulates stability of C53\/LZAP and DDRGK domain-containing Protein 1 (DDRGK1) and modulates NF-kappaB signaling. J Biol Chem. 2010;285:15126\u201336.","journal-title":"J Biol Chem"},{"key":"2681_CR14","doi-asserted-by":"publisher","first-page":"e1005643","DOI":"10.1371\/journal.pgen.1005643","volume":"11","author":"Y Cai","year":"2015","unstructured":"Cai Y, Pi W, Sivaprakasam S, Zhu X, Zhang M, Chen J, Makala L, Lu C, Wu J, Teng Y, Pace B, Tuan D, Singh N, Li H. UFBP1, a Key Component of the Ufm1 Conjugation System, Is Essential for Ufmylation-Mediated Regulation of Erythroid Development. PLoS Genet. 2015;11:e1005643.","journal-title":"PLoS Genet"},{"key":"2681_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41419-021-03401-8","volume":"12","author":"M Quintero","year":"2021","unstructured":"Quintero M, Liu S, Xia Y, Huang Y, Zou Y, Li G, Hu L, Singh N, Blumberg R, Cai Y, Xu H, Li H. Cdk5rap3 is essential for intestinal Paneth cell development and maintenance. Cell Death Dis. 2021;12:131.","journal-title":"Cell Death Dis"},{"key":"2681_CR16","doi-asserted-by":"crossref","unstructured":"Zhu HB, Bhatt B, Sivaprakasam S, Cai YF, Liu SY, Kodeboyina SK, Patel N, Savage NM, Sharma A, Kaufman RJ, Li HL, Singh N. Ufbp1 promotes plasma cell development and ER expansion by modulating distinct branches of UPR. Nat Commun. 2019;10:1084.","DOI":"10.1038\/s41467-019-08908-5"},{"key":"2681_CR17","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.cell.2020.02.017","volume":"180","author":"JR Liang","year":"2020","unstructured":"Liang JR, Lingeman E, Luong T, Ahmed S, Muhar M, Nguyen T, Olzmann JA, Corn JE. A Genome-wide ER-phagy Screen Highlights Key Roles of Mitochondrial Metabolism and ER-Resident UFMylation. Cell. 2020;180:1160-77.e20.","journal-title":"Cell"},{"key":"2681_CR18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1021\/acschembio.7b00020","volume":"12","author":"AM Roberts","year":"2017","unstructured":"Roberts AM, Miyamoto DK, Huffman TR, Bateman LA, Ives AN, Akopian D, Heslin MJ, Contreras CM, Rape M, Skibola CF, Nomura DK. Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target. ACS Chem Biol. 2017;12:899\u2013904.","journal-title":"ACS Chem Biol"},{"key":"2681_CR19","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, Schulte C, Keller MF, Arepalli S, Letson C, Edsall C, Stefansson H, Liu X, Pliner H, Lee JH, Cheng R, Ikram MA, Ioannidis JP, Hadjigeorgiou GM, Bis JC, Martinez M, Perlmutter JS, Goate A, Marder K, Fiske B, Sutherland M, Xiromerisiou G, Myers RH, Clark LN, Stefansson K, Hardy JA, Heutink P, Chen H, Wood NW, Houlden H, Payami H, Brice A, Scott WK, Gasser T, Bertram L, Eriksson N, Foroud T, Singleton AB. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat Genet. 2014;46:989\u201393.","journal-title":"Nat Genet"},{"key":"2681_CR20","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ajhg.2016.06.030","volume":"99","author":"E Colin","year":"2016","unstructured":"Colin E, Daniel J, Ziegler A, Wakim J, Scrivo A, Haack TB, Khiati S, Denomm\u00e9 AS, Amati-Bonneau P, Charif M, Procaccio V, Reynier P, Aleck KA, Botto LD, Herper CL, Kaiser CS, Nabbout R, N\u2019Guyen S, Mora-Lorca JA, Assmann B, Christ S, Meitinger T, Strom TM, Prokisch H, Miranda-Vizuete A, Hoffmann GF, Lenaers G, Bomont P, Liebau E, Bonneau D. Biallelic Variants in UBA5 Reveal that Disruption of the UFM1 Cascade Can Result in Early-Onset Encephalopathy. Am J Hum Genet. 2016;99:695\u2013703.","journal-title":"Am J Hum Genet"},{"key":"2681_CR21","doi-asserted-by":"publisher","first-page":"e004917","DOI":"10.1161\/CIRCHEARTFAILURE.118.004917","volume":"11","author":"J Li","year":"2018","unstructured":"Li J, Yue G, Ma W, Zhang A, Zou J, Cai Y, Tang X, Wang J, Liu J, Li H. Ufm1-specific ligase Ufl1 regulates endoplasmic reticulum homeostasis and protects against heart failure. Circ Heart Fail. 2018;11:e004917.","journal-title":"Circ Heart Fail"},{"key":"2681_CR22","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1172\/JCI90193","volume":"127","author":"AT Egunsola","year":"2017","unstructured":"Egunsola AT, Bae Y, Jiang M-M, Liu DS, Chen-Evenson Y, Bertin T, Chen S, Lu JT, Nevarez L, Magal N, Raas-Rothschild A, Swindell EC, Cohn DH, Gibbs RA, Campeau PM, Shohat M, Lee BH. Loss of DDRGK1 modulates SOX9 ubiquitination in spondyloepimetaphyseal dysplasia. J Clin Invest. 2017;127:1475\u201384.","journal-title":"J Clin Invest"},{"key":"2681_CR23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/cge.13134","volume":"93","author":"M Di Rocco","year":"2018","unstructured":"Di Rocco M, Rusmini M, Caroli F, Madeo A, Bertamino M, Marre-Brunenghi G, Ceccherini I. Novel spondyloepimetaphyseal dysplasia due to UFSP2 gene mutation. Clin Genet. 2018;93:671\u20134.","journal-title":"Clin Genet"},{"key":"2681_CR24","doi-asserted-by":"publisher","first-page":"G314","DOI":"10.1152\/ajpgi.00176.2016","volume":"312","author":"C Miller","year":"2017","unstructured":"Miller C, Cai Y, Patton T, Graves SH, Li H, Sabbatini ME. RCAD\/BiP pathway is necessary for the proper synthesis of digestive enzymes and secretory function of the exocrine pancreas. Am J Physiol Gastrointest Liver Physiol. 2017;312:G314\u201326.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2681_CR25","doi-asserted-by":"crossref","unstructured":"Yang R, Wang H, Kang B, Chen B, Shi Y, Yang S, Sun L, Liu Y, Xiao W, Zhang T, Yang J, Zhang Y, Zhu M, Xu P, Chang Y, Jia Y, Huang Y. CDK5RAP3, a UFL1 substrate adaptor, is crucial for liver development. Development. 2019;146:dev169235.","DOI":"10.1242\/dev.169235"},{"key":"2681_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41421-018-0070-x","volume":"5","author":"Y Cai","year":"2019","unstructured":"Cai Y, Zhu G, Liu S, Pan Z, Quintero M, Poole CJ, Lu C, Zhu H, Islam B, Riggelen JV, Browning D, Liu K, Blumberg R, Singh N, Li H. Indispensable role of the Ubiquitin-fold modifier 1-specific E3 ligase in maintaining intestinal homeostasis and controlling gut inflammation. Cell Discov. 2019;5:7.","journal-title":"Cell Discov"},{"key":"2681_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ncomms1182","volume":"2","author":"K Tatsumi","year":"2011","unstructured":"Tatsumi K, Yamamoto-Mukai H, Shimizu R, Waguri S, Sou Y-S, Sakamoto A, Taya C, Shitara H, Hara T, Chung CH. The Ufm1-activating enzyme Uba5 is indispensable for erythroid differentiation in mice. Nat Commun. 2011;2:181.","journal-title":"Nat Commun"},{"key":"2681_CR28","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1038\/cdd.2015.51","volume":"22","author":"M Zhang","year":"2015","unstructured":"Zhang M, Zhu X, Zhang Y, Cai Y, Chen J, Sivaprakasam S, Gurav A, Pi W, Makala L, Wu J. RCAD\/Ufl1, a Ufm1 E3 ligase, is essential for hematopoietic stem cell function and murine hematopoiesis. Cell Death Differ. 2015;22:1922.","journal-title":"Cell Death Differ"},{"key":"2681_CR29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274\u201393.","journal-title":"Cell"},{"key":"2681_CR30","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1002\/hep.30770","volume":"70","author":"HM Ni","year":"2019","unstructured":"Ni HM, Chao X, Yang H, Deng F, Wang S, Bai Q, Qian H, Cui Y, Cui W, Shi Y, Zong WX, Wang Z, Yang L, Ding WX. Dual Roles of Mammalian Target of Rapamycin in Regulating Liver Injury and Tumorigenesis in Autophagy-Defective Mouse Liver. Hepatology. 2019;70:2142\u201355.","journal-title":"Hepatology"},{"key":"2681_CR31","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nrd3531","volume":"10","author":"D Benjamin","year":"2011","unstructured":"Benjamin D, Colombi M, Moroni C, Hall MN. Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat Rev Drug Discov. 2011;10:868\u201380.","journal-title":"Nat Rev Drug Discov"},{"key":"2681_CR32","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.26323","volume":"58","author":"M Bhat","year":"2013","unstructured":"Bhat M, Sonenberg N, Gores GJ. The mTOR pathway in hepatic malignancies. Hepatology. 2013;58:810\u20138.","journal-title":"Hepatology"},{"key":"2681_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.yexmp.2014.05.010","volume":"97","author":"H Liu","year":"2014","unstructured":"Liu H, Li J, Tillman B, French BA, French SW. Ufmylation and FATylation pathways are downregulated in human alcoholic and nonalcoholic steatohepatitis, and mice fed DDC, where Mallory-Denk bodies (MDBs) form. Exp Mol Pathol. 2014;97:81\u20138.","journal-title":"Exp Mol Pathol"},{"key":"2681_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fendo.2015.00036","volume":"6","author":"HM Yoo","year":"2015","unstructured":"Yoo HM, Park JH, Jeon YJ, Chung CH. Ubiquitin-fold modifier 1 acts as a positive regulator of breast cancer. Front Endocrinol (Lausanne). 2015;6:36.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2681_CR35","doi-asserted-by":"crossref","unstructured":"Recena Aydos L, Aparecida do Amaral L, Serafim de Souza R, Jacobowski AC, Freitas Dos Santos E, Rodrigues Macedo ML. Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in C57bl\/6 Models. Nutrients. 2019;11:3067.","DOI":"10.3390\/nu11123067"},{"key":"2681_CR36","doi-asserted-by":"publisher","first-page":"36037","DOI":"10.1038\/srep36037","volume":"6","author":"L Shan","year":"2016","unstructured":"Shan L, Ding Y, Fu Y, Zhou L, Dong X, Chen S, Wu H, Nai W, Zheng H, Xu W, Bai X, Jia C, Dai M. mTOR Overactivation in Mesenchymal cells Aggravates CCl(4)- Induced liver Fibrosis. Sci Rep. 2016;6:36037.","journal-title":"Sci Rep"},{"key":"2681_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s13238-017-0409-3","volume":"9","author":"J Han","year":"2018","unstructured":"Han J, Wang Y. mTORC1 signaling in hepatic lipid metabolism. Protein cell. 2018;9:145\u201351.","journal-title":"Protein cell"},{"key":"2681_CR38","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00535-013-0780-7","volume":"49","author":"M Hamano","year":"2014","unstructured":"Hamano M, Ezaki H, Kiso S, Furuta K, Egawa M, Kizu T, Chatani N, Kamada Y, Yoshida Y, Takehara T. Lipid overloading during liver regeneration causes delayed hepatocyte DNA replication by increasing ER stress in mice with simple hepatic steatosis. J Gastroenterol. 2014;49:305\u201316.","journal-title":"J Gastroenterol"},{"key":"2681_CR39","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/jcp.24923","volume":"230","author":"G Zhu","year":"2015","unstructured":"Zhu G, Lee AS. Role of the unfolded protein response, GRP78 and GRP94 in organ homeostasis. J Cell Physiol. 2015;230:1413\u201320.","journal-title":"J Cell Physiol"},{"key":"2681_CR40","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.molcel.2007.12.023","volume":"29","author":"U Ozcan","year":"2008","unstructured":"Ozcan U, Ozcan L, Yilmaz E, D\u00fcvel K, Sahin M, Manning BD, Hotamisligil GS. Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol Cell. 2008;29:541\u201351.","journal-title":"Mol Cell"},{"key":"2681_CR41","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1172\/JCI44771","volume":"121","author":"K Inoki","year":"2011","unstructured":"Inoki K, Mori H, Wang J, Suzuki T, Hong S, Yoshida S, Blattner SM, Ikenoue T, R\u00fcegg MA, Hall MN, Kwiatkowski DJ, Rastaldi MP, Huber TB, Kretzler M, Holzman LB, Wiggins RC, Guan KL. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest. 2011;121:2181\u201396.","journal-title":"J Clin Invest"},{"key":"2681_CR42","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12032-009-9201-4","volume":"27","author":"L Zhou","year":"2010","unstructured":"Zhou L, Huang Y, Li J, Wang Z. The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma. Med Oncol. 2010;27:255\u201361.","journal-title":"Med Oncol"},{"key":"2681_CR43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.bbcan.2019.03.001","volume":"1871","author":"XN Yu","year":"2019","unstructured":"Yu XN, Chen H, Liu TT, Wu J, Zhu JM, Shen XZ. Targeting the mTOR regulatory network in hepatocellular carcinoma: Are we making headway? Biochim Biophys Acta Rev Cancer. 2019;1871:379\u201391.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2681_CR44","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1038\/s41388-019-0713-x","volume":"38","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Su S, Zhang Y, Qian J, Liu P. Control of mTOR signaling by ubiquitin. Oncogene. 2019;38:3989\u20134001.","journal-title":"Oncogene"},{"key":"2681_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2015.09.001","volume":"23","author":"J Qi","year":"2015","unstructured":"Qi J, Ronai ZA. Dysregulation of ubiquitin ligases in cancer. Drug Resist Updat. 2015;23:1\u201311.","journal-title":"Drug Resist Updat"},{"key":"2681_CR46","doi-asserted-by":"publisher","first-page":"F1046","DOI":"10.1152\/ajprenal.00350.2017","volume":"314","author":"DK Panda","year":"2018","unstructured":"Panda DK, Bai X, Sabbagh Y, Zhang Y, Zaun HC, Karellis A, Koromilas AE, Lipman ML, Karaplis AC. Defective interplay between mTORC1 activity and endoplasmic reticulum stress-unfolded protein response in uremic vascular calcification. Am J Physiol Renal Physiol. 2018;314:F1046\u201361.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2681_CR47","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1038\/ncomms5233","volume":"5","author":"HW Park","year":"2014","unstructured":"Park HW, Park H, Ro SH, Jang I, Semple IA, Kim DN, Kim M, Nam M, Zhang D, Yin L, Lee JH. Hepatoprotective role of Sestrin2 against chronic ER stress. Nat Commun. 2014;5:4233.","journal-title":"Nat Commun"},{"key":"2681_CR48","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS. Hepatocellular carcinoma Nat Rev Dis Primers. 2021;7:6.","journal-title":"Hepatocellular carcinoma Nat Rev Dis Primers"},{"key":"2681_CR49","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jhep.2006.07.030","volume":"45","author":"M Neef","year":"2006","unstructured":"Neef M, Ledermann M, Saegesser H, Schneider V, Reichen J. Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis. J Hepatol. 2006;45:786\u201396.","journal-title":"J Hepatol"},{"issue":"8","key":"2681_CR50","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s43587-021-00098-4","volume":"1","author":"Y Aman","year":"2021","unstructured":"Aman Y, Schmauck-Medina T, Hansen M, Morimoto RI, Simon AK, Bjedov I, Palikaras K, Simonsen A, Johansen T, Tavernarakis N, Rubinsztein DC, Partridge L, Kroemer G, Labbadia J, Fang EF. Autophagy in healthy aging and disease. Nat Aging. 2021;1(8):634\u201350.","journal-title":"Nat Aging"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02681-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-023-02681-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02681-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T03:26:58Z","timestamp":1683084418000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-023-02681-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,3]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2681"],"URL":"https:\/\/doi.org\/10.1186\/s13046-023-02681-6","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,3]]},"assertion":[{"value":"10 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of Nanjing Agricultural University (31672512).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}